T1	PROC 46 61	Ensayo fase III
T2	CHEM 65 74	nivolumab
#1	AnnotatorNotes T2	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	CHEM 76 85	nivolumab
#2	AnnotatorNotes T3	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	CHEM 105 115	ipilimumab
#3	AnnotatorNotes T4	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	PROC 118 125	placebo
#4	AnnotatorNotes T5	C0032042; Placebos; Therapeutic or Preventive Procedure
T6	PROC 131 159	tratamiento de mantenimiento
#5	AnnotatorNotes T6	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T7	DISO 175 228	cáncer microcítico de pulmón con enfermedad extendida
#6	AnnotatorNotes T7	C0278726; Small cell lung cancer extensive stage; Neoplastic Process
T8	ANAT 197 203	pulmón
#7	AnnotatorNotes T8	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T9	DISO 230 233	CMP
T10	PROC 262 292	quimioterapia de primera línea
#8	AnnotatorNotes T10	C2045825; chemotherapeutics regimen first line of treatment; Therapeutic or Preventive Procedure
T11	CHEM 303 310	platino
#9	AnnotatorNotes T11	C0032207; platinum; Element, Ion, or Isotope
T12	PROC 361 417	Ensayo fase III aleatorizado, multicéntrico, doble ciego
T13	CHEM 422 431	nivolumab
#10	AnnotatorNotes T13	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	CHEM 433 442	nivolumab
#11	AnnotatorNotes T14	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T15	CHEM 462 472	ipilimumab
#12	AnnotatorNotes T15	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T16	PROC 475 482	placebo
#13	AnnotatorNotes T16	C0032042; Placebos; Therapeutic or Preventive Procedure
T17	PROC 488 516	tratamiento de mantenimiento
#14	AnnotatorNotes T17	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T18	DISO 532 585	cáncer microcítico de pulmón con enfermedad extendida
#15	AnnotatorNotes T18	C0278726; Small cell lung cancer extensive stage; Neoplastic Process
T19	ANAT 554 560	pulmón
#16	AnnotatorNotes T19	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T20	DISO 587 590	CMP
T21	PROC 619 649	quimioterapia de primera línea
#17	AnnotatorNotes T21	C2045825; chemotherapeutics regimen first line of treatment; Therapeutic or Preventive Procedure
T22	CHEM 660 667	platino
#18	AnnotatorNotes T22	C0032207; platinum; Element, Ion, or Isotope
T23	DISO 691 707	Cáncer de pulmón
#19	AnnotatorNotes T23	C0242379; Malignant neoplasm of lung; Neoplastic Process | C0684249; Carcinoma of lung; Neoplastic Process
T24	DISO 734 787	Cáncer microcítico de pulmón con enfermedad extendida
#20	AnnotatorNotes T24	C0278726; Small cell lung cancer extensive stage; Neoplastic Process
T25	ANAT 756 762	pulmón
#21	AnnotatorNotes T25	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T26	DISO 789 792	CMP
T27	PROC 821 851	quimioterapia de primera línea
#22	AnnotatorNotes T27	C2045825; chemotherapeutics regimen first line of treatment; Therapeutic or Preventive Procedure
T28	CHEM 862 869	platino
#23	AnnotatorNotes T28	C0032207; platinum; Element, Ion, or Isotope
T29	DISO 910 913	CMP
T30	PROC 1000 1030	quimioterapia de primera línea
#24	AnnotatorNotes T30	C2045825; chemotherapeutics regimen first line of treatment; Therapeutic or Preventive Procedure
T31	CHEM 1041 1048	platino
#25	AnnotatorNotes T31	C0032207; platinum; Element, Ion, or Isotope
T32	PROC 1116 1129	quimioterapia
#26	AnnotatorNotes T32	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T33	PROC 1275 1286	tratamiento
#27	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	DISO 1304 1330	enfermedad autoinmunitaria
#28	AnnotatorNotes T34	C0004364; Autoimmune Diseases; Disease or Syndrome
T35	DISO 1373 1389	efectos adversos
#29	AnnotatorNotes T35	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T36	PROC 1404 1426	tratamiento oncológico
#30	AnnotatorNotes T36	C0920425; cancer treatment; Therapeutic or Preventive Procedure
T37	ANAT 182 193	microcítico
#31	AnnotatorNotes T37	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T38	ANAT 539 550	microcítico
#32	AnnotatorNotes T38	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T39	ANAT 701 707	pulmón
#33	AnnotatorNotes T39	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T40	ANAT 741 752	microcítico
#34	AnnotatorNotes T40	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T41	PROC 938 948	histología
#35	AnnotatorNotes T41	C0344441; Histology Procedure; Laboratory Procedure
T42	DISO 1252 1270	Metástasis del SNC
T43	ANAT 1267 1270	SNC
#36	AnnotatorNotes T43	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T44	Date 13 17	2015
T45	LIVB 163 170	sujetos
#37	AnnotatorNotes T45	C0681850; Study Subject; Group
T46	LIVB 520 527	sujetos
#38	AnnotatorNotes T46	C0681850; Study Subject; Group
T47	LIVB 898 905	Sujetos
#39	AnnotatorNotes T47	C0681850; Study Subject; Group
T48	LIVB 959 966	sujetos
#40	AnnotatorNotes T48	C0681850; Study Subject; Group
T50	LIVB 1238 1247	Pacientes
#41	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Neg_cue 1271 1274	sin
T52	LIVB 1290 1299	Pacientes
#42	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Spec_cue 1350 1360	sospechada
T49	PROC 1132 1148	Estado funcional
#43	AnnotatorNotes T49	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T54	PROC 1150 1152	EF
#44	AnnotatorNotes T54	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
A1	Assertion T33 Negated
A2	Assertion T34 Speculated
A3	Status T34 History_of
A4	Status T30 History_of
A5	Status T31 History_of
A6	Status T32 History_of
A7	Status T27 History_of
A8	Status T28 History_of
A9	Status T36 History_of
A10	Status T21 History_of
A11	Status T22 History_of
A12	Status T10 History_of
A13	Status T11 History_of
#45	AnnotatorNotes T1	C0282461; Phase 3 Clinical Trials; Research Activity
#46	AnnotatorNotes T9	C0278726; Small cell lung cancer extensive stage; Neoplastic Process
#47	AnnotatorNotes T26	C0278726; Small cell lung cancer extensive stage; Neoplastic Process
#48	AnnotatorNotes T20	C0278726; Small cell lung cancer extensive stage; Neoplastic Process
#49	AnnotatorNotes T29	C0278726; Small cell lung cancer extensive stage; Neoplastic Process
#50	AnnotatorNotes T42	C0686377; CNS metastases; Neoplastic Process
#51	AnnotatorNotes T12	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C1096776; Multicenter Study; Research Activity + C0013072; Double-Blind Method; Research Activity
R1	Combined_with Arg1:T3 Arg2:T4	
R2	Used_for Arg1:T2 Arg2:T6	
R3	Used_for Arg1:T3 Arg2:T6	
R4	Used_for Arg1:T5 Arg2:T6	
R5	Experiences Arg1:T45 Arg2:T2	
R6	Experiences Arg1:T45 Arg2:T3	
R7	Experiences Arg1:T45 Arg2:T5	
R8	Experiences Arg1:T45 Arg2:T7	
R9	Location_of Arg1:T37 Arg2:T7	
R10	Location_of Arg1:T8 Arg2:T7	
R11	Location_of Arg1:T8 Arg2:T9	
R12	Location_of Arg1:T37 Arg2:T9	
R13	Experiences Arg1:T45 Arg2:T9	
R14	After Arg1:T2 Arg2:T10	
R15	After Arg1:T3 Arg2:T10	
R16	After Arg1:T5 Arg2:T10	
R17	Used_for Arg1:T11 Arg2:T10	
T55	Quantifier_or_Qualifier 314 338	multiples localizaciones
R18	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T55	
R19	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T55	
R20	Combined_with Arg1:T14 Arg2:T15	
R21	Used_for Arg1:T16 Arg2:T17	
R22	Used_for Arg1:T14 Arg2:T17	
R23	Used_for Arg1:T13 Arg2:T17	
R24	Experiences Arg1:T46 Arg2:T13	
R25	Experiences Arg1:T46 Arg2:T14	
R26	Experiences Arg1:T46 Arg2:T16	
R27	Experiences Arg1:T46 Arg2:T18	
R28	Location_of Arg1:T38 Arg2:T18	
R29	Location_of Arg1:T19 Arg2:T18	
R30	Location_of Arg1:T19 Arg2:T20	
R31	Location_of Arg1:T38 Arg2:T20	
R32	After Arg1:T13 Arg2:T21	
R33	After Arg1:T14 Arg2:T21	
R34	After Arg1:T16 Arg2:T21	
R35	Used_for Arg1:T22 Arg2:T21	
R36	Experiences Arg1:T46 Arg2:T20	
R37	Experiences Arg1:T46 Arg2:T21	
R38	Experiences Arg1:T45 Arg2:T10	
R39	Location_of Arg1:T39 Arg2:T23	
R40	Location_of Arg1:T25 Arg2:T24	
R41	Location_of Arg1:T40 Arg2:T24	
R42	Location_of Arg1:T25 Arg2:T26	
R43	Location_of Arg1:T40 Arg2:T26	
R44	After Arg1:T24 Arg2:T27	
R45	After Arg1:T26 Arg2:T27	
R46	Used_for Arg1:T28 Arg2:T27	
R47	After Arg1:T18 Arg2:T21	
R48	After Arg1:T20 Arg2:T21	
R49	After Arg1:T9 Arg2:T10	
R50	After Arg1:T7 Arg2:T10	
R51	Experiences Arg1:T47 Arg2:T29	
R53	Experiences Arg1:T47 Arg2:T41	
R54	Experiences Arg1:T48 Arg2:T30	
T56	Quantifier_or_Qualifier 988 996	4 ciclos
R55	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T56	
R56	Used_for Arg1:T31 Arg2:T30	
T57	Observation 1067 1092	respuesta que se mantiene
R57	Experiences Arg1:T48 Arg2:T57	
R58	After Arg1:T57 Arg2:T32	
T58	Result_or_Value 1203 1208	0 o 1
T59	CONC 1194 1198	ECOG
#52	AnnotatorNotes T59	C1520224; ECOG performance status; Intellectual Product
R59	Has_Result_or_Value Arg1:T59 Arg2:T58	
T60	CONC 1158 1192	Eastern Cooperative Oncology Group
#53	AnnotatorNotes T60	C1520224; ECOG performance status; Intellectual Product
R60	Used_for Arg1:T60 Arg2:T49	
R61	Used_for Arg1:T60 Arg2:T54	
R62	Used_for Arg1:T59 Arg2:T54	
R63	Used_for Arg1:T59 Arg2:T49	
R64	Has_Result_or_Value Arg1:T60 Arg2:T58	
R65	Experiences Arg1:T50 Arg2:T42	
R66	Location_of Arg1:T43 Arg2:T42	
R67	Negation Arg1:T51 Arg2:T33	
R68	Experiences Arg1:T50 Arg2:T33	
R69	Experiences Arg1:T52 Arg2:T34	
R70	Speculation Arg1:T53 Arg2:T34	
T61	Quantifier_or_Qualifier 1331 1337	activa
#54	AnnotatorNotes T61	C0679217; Active State; Idea or Concept
R71	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T61	
R72	Causes Arg1:T36 Arg2:T35	
T62	Quantifier_or_Qualifier 1459 1466	grado 1
R73	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T62	
T63	Quantifier_or_Qualifier 1469 1480	nivel basal
#55	AnnotatorNotes T63	C1442488; Baseline; Quantitative Concept
R74	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T63	
R75	Experiences Arg1:T48 Arg2:T32	
R76	Used_for Arg1:T31 Arg2:T32	
#56	AnnotatorNotes T62	C0444502; First degree; Qualitative Concept
A14	Experiencer T47 Patient
A15	Experiencer T48 Patient
A16	Experiencer T50 Patient
A17	Experiencer T45 Patient
A18	Experiencer T46 Patient
A19	Experiencer T52 Patient
